Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 7 studies | 36% ± 16% | |
fibroblast | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 25% ± 3% | |
glutamatergic neuron | 3 studies | 32% ± 4% | |
basal cell | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 3 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1584.60 | 180 / 180 | 100% | 11.16 | 429 / 430 |
breast | 100% | 1903.35 | 459 / 459 | 100% | 12.38 | 1115 / 1118 |
brain | 100% | 1264.83 | 2630 / 2642 | 100% | 15.72 | 705 / 705 |
prostate | 100% | 1711.67 | 245 / 245 | 99% | 8.42 | 499 / 502 |
uterus | 100% | 1313.66 | 170 / 170 | 99% | 15.40 | 456 / 459 |
lung | 99% | 1041.58 | 571 / 578 | 100% | 13.37 | 1151 / 1155 |
esophagus | 100% | 1204.79 | 1445 / 1445 | 98% | 11.72 | 180 / 183 |
adrenal gland | 100% | 1767.88 | 258 / 258 | 98% | 13.19 | 226 / 230 |
thymus | 100% | 1096.66 | 650 / 653 | 98% | 10.13 | 594 / 605 |
skin | 100% | 2475.82 | 1809 / 1809 | 97% | 11.61 | 459 / 472 |
bladder | 100% | 1216.38 | 21 / 21 | 97% | 9.16 | 487 / 504 |
intestine | 93% | 711.92 | 901 / 966 | 95% | 5.46 | 499 / 527 |
kidney | 93% | 583.60 | 83 / 89 | 90% | 5.75 | 813 / 901 |
stomach | 82% | 591.12 | 294 / 359 | 94% | 5.56 | 270 / 286 |
pancreas | 72% | 281.91 | 235 / 328 | 98% | 5.57 | 174 / 178 |
blood vessel | 100% | 2314.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.33 | 1 / 1 |
adipose | 100% | 1114.58 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1175.23 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 883.31 | 802 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 6.63 | 73 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 3.29 | 24 / 29 |
spleen | 83% | 323.43 | 199 / 241 | 0% | 0 | 0 / 0 |
liver | 12% | 41.68 | 26 / 226 | 54% | 2.80 | 220 / 406 |
peripheral blood | 19% | 123.76 | 173 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060271 | Biological process | cilium assembly |
GO_0030111 | Biological process | regulation of Wnt signaling pathway |
GO_0032391 | Cellular component | photoreceptor connecting cilium |
GO_0120199 | Cellular component | cone photoreceptor outer segment |
GO_0035869 | Cellular component | ciliary transition zone |
GO_0120200 | Cellular component | rod photoreceptor outer segment |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM237 |
Protein name | Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein) Transmembrane protein 237 Alternative protein TMEM237 |
Synonyms | ALS2CR4 |
Description | FUNCTION: Component of the transition zone in primary cilia. Required for ciliogenesis. . FUNCTION: Component of the transition zone in primary cilia. Required for ciliogenesis. . FUNCTION: Component of the transition zone in primary cilia. Required for ciliogenesis. . |
Accessions | ENST00000432684.6 ENST00000621467.5 F2Z329 ENST00000409883.7 [Q96Q45-1] ENST00000286196.9 ENST00000409444.6 [Q96Q45-2] L0R6S1 ENST00000444047.6 A0A087WWU1 Q96Q45 F8WE96 |